Journey Medical Statistics
Share Statistics
Journey Medical has 23.12M
shares outstanding. The number of shares has increased by 4.38%
in one year.
| Shares Outstanding | 23.12M |
| Shares Change (YoY) | 4.38% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 18.41% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 3,260 |
| FTD / Avg. Volume | 3.91% |
Short Selling Information
The latest short interest is 332.39K, so 1.44% of the outstanding
shares have been sold short.
| Short Interest | 332.39K |
| Short % of Shares Out | 1.44% |
| Short % of Float | 4.96% |
| Short Ratio (days to cover) | 3.83 |
Valuation Ratios
The PE ratio is -5.44 and the forward
PE ratio is 12.2.
Journey Medical's PEG ratio is
-0.02.
| PE Ratio | -5.44 |
| Forward PE | 12.2 |
| PS Ratio | 1.42 |
| Forward PS | 0.6 |
| PB Ratio | 3.98 |
| P/FCF Ratio | -8.75 |
| PEG Ratio | -0.02 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Journey Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.37,
with a Debt / Equity ratio of 1.25.
| Current Ratio | 1.37 |
| Quick Ratio | 0.96 |
| Debt / Equity | 1.25 |
| Debt / EBITDA | -2.96 |
| Debt / FCF | -2.75 |
| Interest Coverage | -5.07 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $1,369,121.95 |
| Profits Per Employee | $-357,853.66 |
| Employee Count | 41 |
| Asset Turnover | 0.7 |
| Inventory Turnover | 1.45 |
Taxes
| Income Tax | 61K |
| Effective Tax Rate | -0.42% |
Stock Price Statistics
The stock price has increased by 100.58% in the
last 52 weeks. The beta is 0.87, so Journey Medical's
price volatility has been higher than the market average.
| Beta | 0.87 |
| 52-Week Price Change | 100.58% |
| 50-Day Moving Average | 6.37 |
| 200-Day Moving Average | 5.41 |
| Relative Strength Index (RSI) | 53.16 |
| Average Volume (20 Days) | 83,301 |
Income Statement
In the last 12 months, Journey Medical had revenue of 56.13M
and earned -14.67M
in profits. Earnings per share was -0.72.
| Revenue | 56.13M |
| Gross Profit | 35.26M |
| Operating Income | -13.68M |
| Net Income | -14.67M |
| EBITDA | -8.49M |
| EBIT | -11.91M |
| Earnings Per Share (EPS) | -0.72 |
Full Income StatementBalance Sheet
The company has 20.3M in cash and 25.08M in
debt, giving a net cash position of -4.78M.
| Cash & Cash Equivalents | 20.3M |
| Total Debt | 25.08M |
| Net Cash | -4.78M |
| Retained Earnings | -87.03M |
| Total Assets | 84.96M |
| Working Capital | 13.76M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -9.13M
and capital expenditures 0, giving a free cash flow of -9.13M.
| Operating Cash Flow | -9.13M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.13M |
| FCF Per Share | -0.45 |
Full Cash Flow StatementMargins
Gross margin is 62.81%, with operating and profit margins of -24.36% and -26.14%.
| Gross Margin | 62.81% |
| Operating Margin | -24.36% |
| Pretax Margin | -26.03% |
| Profit Margin | -26.14% |
| EBITDA Margin | -15.12% |
| EBIT Margin | -24.36% |
| FCF Margin | -16.26% |
